弹性假黄瘤致Bruch膜矿化眼抗血管内皮生长因子注射后眼压变化
纳入20只弹性假黄瘤(PXE)眼与30只其他视网膜疾病对照眼,注射50 µL抗VEGF药物后1、5、15分钟测眼压并以指数衰减模型计算时间常数tau。两组眼压均明显升高且无显著差异,但PXE组tau中位数8.6分钟 vs 对照组7.6分钟(P=0.02),提示PXE眼眼压恢复至基线所需时间更长。
要点
- PXE组眼压衰减时间常数tau中位数8.6分钟,高于对照组7.6分钟(P=0.02)。
- 注射后两组眼压均明显升高,PXE组与对照组间无显著差异。
- 作者认为PXE患者注射前降眼压措施的临床试验值得考虑。
核心结论
- 抗VEGF注射后眼压恢复至基线的时间在PXE患者中更长。
- 鉴于PXE患者早期即需抗VEGF治疗、注射频繁及可能存在更高易感性(如视盘玻璃疣),作者认为注射前降眼压措施的临床试验值得考虑。
研究设计与样本
- 纳入20只PXE患者眼(平均年龄63.4 ± 6.4岁)和30只对照眼(平均年龄64.8 ± 11.8岁)。
- 在玻璃体腔注射50 µL抗VEGF药物前及注射后1、5、15分钟测量眼压。
- 用指数衰减函数拟合注射后眼压曲线,以指数时间常数(tau)作为多变量模型的结局变量。
主要发现
- 两组注射后眼压均明显升高,PXE组与对照组间无显著差异。
- PXE组tau中位数8.6分钟(四分位距[IQR]=8.2-9.4) vs 对照组7.6分钟(IQR=6.8-8.9),P=0.02。
- 7例PXE患者和1例对照患者报告既往抗VEGF注射后曾出现一过性视力丧失。
- 单因素分析显示PXE诊断(1.12,P=0.006)、血管样条纹长度(0.12,P=0.01)、既往一过性视力丧失(1.77,P=0.001)、外周动脉疾病(0.96,P=0.04)及既往抗VEGF注射次数(0.02,P=0.014)与较高tau值显著相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess acute IOP changes after anti-VEGF injections in patients with Pseudoxanthoma elasticum (PXE) compared to other retinal diseases. METHODS: Twenty eyes of patients with PXE (mean age 63.4 ± 6.4 years) and 30 control eyes (mean age 64.8 ± 11.8 years) were included. IOP was measured prior and one, five, and 15 minutes after intravitreal injection of 50 µL anti-VEGF agent. The post-injection IOP curve was modeled by an exponential decay function, and the resulting exponential time constant (tau) served as the outcome variable in the multivariable models. RESULTS: IOP raised markedly after anti-VEGF injection in both groups, without significant difference in PXE compared to controls. The median tau in the PXE group was 8.6 minutes (interquartile range [IQR] = 8.2-9.4) versus 7.6 minutes (IQR = 6.8-8.9) in the control group (P = 0.02). Seven PXE patients and one control patient reported a previous transient vision loss after anti-VEGF injection. Univariate analysis showed that the diagnosis of PXE (1.12, P = 0.006), angioid streak length (0.12, P = 0.01), prior transient vision loss (1.77, P = 0.001), peripheral artery disease (0.96, P = 0.04) and the number of previous anti-VEGF injections (0.02, P = 0.014) were significantly associated with higher tau values. CONCLUSIONS: The time to restore to baseline IOP after anti-VEGF injection is longer in PXE patients. Given the early need for anti-VEGF treatment, frequent injections, and the possible heightened vulnerability (e.g., optic disc drusen) in PXE patients, clinical trials on pre-injection IOP-lowering measures warrant consideration.
引用
- Raming K, Saltenberger I, Meinke J, et al. Intraocular Pressure After Anti-Vascular Endothelial Growth Factor Injection in Eyes With a Mineralized Bruch's Membrane Caused by Pseudoxanthoma Elasticum. Invest Ophthalmol Vis Sci. 2025. PMID: 40787936. doi:10.1167/iovs.66.11.25
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。